Lv415
676 积分 2023-12-13 加入
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
11天前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
11天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
11天前
已完结
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
14天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
17天前
已完结
Epistaxis after PDE-5 inhibitors misuse
17天前
已完结
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
18天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
24天前
已完结
OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
24天前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
24天前
已完结
皖公网安备34019202002308
